Carisma

Performance

About Carisma

Carisma is a biotechnology company pioneering CAR-Macrophages and CAR-Monocytes for solid tumor immunotherapy, with applications in fibrosis, oncology, and autoimmune disorders. The company focuses on engineering macrophages to modulate the tumor microenvironment and enhance anti-tumor activity. Their work centers on macrophage- and monocyte-based cell therapies aimed at solid tumors, with broader implications for fibrotic and autoimmune diseases.